Editorial: Omics-based Novel Computational Methods Revealing Microbe-Disease Associations

Stephen S.-T. Yau,Qi Wu

DOI: https://doi.org/10.3389/fcimb.2023.1305902

IF: 6.073

2023-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:EDITORIAL article Front. Cell. Infect. Microbiol., 26 October 2023Sec. Extra-intestinal Microbiome Volume 13 - 2023 | https://doi.org/10.3389/fcimb.2023.1305902

What problem does this paper attempt to address?

Host and Microbiome Multi-Omics Integration: Applications and Methodologies.

Qing Wang,Kaicen Wang,Wenrui Wu,Eleni Giannoulatou,Joshua W. K. Ho,Lanjuan Li

DOI: https://doi.org/10.1007/s12551-018-0491-7

2019-01-01

Biophysical Reviews

Abstract:The study of the microbial community—the microbiome—associated with a human host is a maturing research field. It is increasingly clear that the composition of the human’s microbiome is associated with various diseases such as gastrointestinal diseases, liver diseases and metabolic diseases. Using high-throughput technologies such as next-generation sequencing and mass spectrometry–based metabolomics, we are able to comprehensively sequence the microbiome—the metagenome—and associate these data with the genomic, epigenomics, transcriptomic and metabolic profile of the host. Our review summarises the application of integrating host omics with microbiome as well as the analytical methods and related tools applied in these studies. In addition, potential future directions are discussed.
Editorial: Molecular insight of chronic infections.

Honghua Hu,Leyi Wang,Qi Zhao

DOI: https://doi.org/10.3389/fmicb.2022.1112456

IF: 5.2

2023-01-01

Frontiers in Microbiology

Abstract:EDITORIAL article Front. Microbiol., 04 January 2023Sec. Systems Microbiology Volume 13 - 2022 | https://doi.org/10.3389/fmicb.2022.1112456
Editorial: New insights into the role of mycobiome in diseases.

Wenjuan Wu,Jun Ding,Xiaoqi Zheng,Hui Wang,Ning-Ning Liu

DOI: https://doi.org/10.3389/fcimb.2023.1240657

IF: 6.073

2023-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:EDITORIAL article Front. Cell. Infect. Microbiol., 30 June 2023Sec. Fungal Pathogenesis Volume 13 - 2023 | https://doi.org/10.3389/fcimb.2023.1240657
Editorial: the Relationship of Oral and Other Body Sites Microbiome in Human Diseases

Tiansong Xu,Ning Chen,Xuesong He,Feng Chen

DOI: https://doi.org/10.3389/fcimb.2023.1276473

IF: 6.073

2023-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:EDITORIAL article Front. Cell. Infect. Microbiol., 23 August 2023Sec. Extra-intestinal Microbiome Volume 13 - 2023 | https://doi.org/10.3389/fcimb.2023.1276473
Application of Omics and Bioinformatics Tools in Streptococcus Research.

Min Liao,Ting Tong,Yawen Zong,Xuedong Zhou,Lei Cheng,Ruijie Huang,Biao Ren,Gil Alterovitz

DOI: https://doi.org/10.21775/cimb.032.327

2019-01-01

Current Issues in Molecular Biology

Abstract:Researchers used to focus on analyzing single gene or protein expression of the microbes. But recently, genome, transcriptome, proteome and metabolome have gained more and more attention. Based on technologies of omics, including genomics, transcriptomics and metabolomics, a large quantity of information about cells, microbes and human, such as the information about phylogeny, virulence, antibiotic resistance and other aspects, has been revealed. Genus Streptococcus is one of the most invasive groups of bacteria that cause both human and animal diseases, threatening public health. In this review, we summarize the application of omics to analyze this genus-Streptococcus.
Editorial: Computational and systematic analysis of multi-omics data for drug discovery and development

Shicheng Guo,Dake Zhang,Hu Wang,Qin An,Guangchuang Yu,Junwei Han,Chunjie Jiang,Jianfeng Huang

DOI: https://doi.org/10.3389/fmed.2023.1146896

IF: 3.9

2023-01-01

Frontiers in Medicine

Abstract:EDITORIAL article Front. Med., 21 February 2023Sec. Translational Medicine Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1146896
Editorial: Molecular insights of microbiota and innate lymphoid cell interactions

José Luís Fachi,Marcela Davoli Ferreira,Niels Olsen Saraiva Câmara

DOI: https://doi.org/10.3389/fimmu.2024.1497305

IF: 7.3

2024-10-11

Frontiers in Immunology

Abstract:In the dynamic field of immunology, the discovery of innate lymphoid cells (ILCs) in 2008 marked a transformative milestone, as highlighted by Vivier et al. (2018). These cells, present in both humans and mice, have become central to research due to their crucial role in maintaining barrier immunity and their involvement in a range of microbiota-driven disorders.ILCs are a diverse group of cells categorized into three main subsets based on their expression of transcription factors and cytokines (Vivier et al., 2018). Group 1 ILCs (including ILC1 and NK cells) are characterized by the expression of T-bet and IFN-γ, mirroring the function of Th1 cells.Group 2 ILCs express GATA3 and cytokines such as IL-4, IL-5, and IL-13, resembling Th2 cells.Group 3 ILCs, defined by the expression of RORγt and production of are analogous to Th17 cells. Although ILCs perform functions similar to adaptive T cells, they are distinguished by the absence of antigen-specific receptors. Instead, their activation and responses are mediated through cytokine and alarmin signaling. These cells are primarily located at mucosal surfaces and other barrier sites and act as a crucial first line of defense by rapidly producing cytokines that orchestrate immune responses and maintain tissue homeostasis. Their role in health and disease is increasingly recognized, particularly in conditions such as inflammatory bowel diseases, cancer, autoimmunity, and metabolic disorders. A key aspect of their function is their interaction with the microbiota-a complex and diverse community of microorganisms essential for shaping host immunity. In particular, the gut microbiota influences immune cell development, modulates inflammatory responses, and impacts systemic immunity (Zheng et al., 2020). Positioned strategically at these barrier sites, ILCs are well-equipped to sense microbial signals and respond accordingly, helping to maintain a balanced immune environment. Disruptions in this crosstalk can lead to dysbiosis, driving the onset and progression of various diseases. Understanding these interactions holds significant potential for developing microbiota-targeted therapies that could restore immune balance and offer new approaches to disease treatment and prevention. In addition to exploring these biological interactions, the integration of multi-omics technologies and artificial intelligence (AI) has opened new avenues for investigating the complex relationships between immune cells and their environment. Xu et al. contribution within this Research Topic utilizes these advanced approaches to uncover new neutrophil clusters and potential biomarkers in sepsis, offering valuable insights into the immune landscape during severe infection. This research not only enhances our understanding of sepsis but also illustrates the potential of integrating multi-

immunology
Editorial: Proteomic Approaches to Unravel Mechanisms of Resistance and Immune Evasion of Bacterial Pathogens

Eva Torres-Sangiao,Alexander Dyason Giddey,Cristina Leal Rodriguez,Zhiheng Tang,Xiaoyun Liu,Nelson C. Soares

DOI: https://doi.org/10.3389/fmed.2022.945264

IF: 3.9

2022-01-01

Frontiers in Medicine

Abstract:The profound effects of and distress caused by the global COVID-19 pandemic highlighted what has been known in the health sciences a long time ago: that bacteria, fungi, viruses, and parasites continue to present a major threat to human health. Infectious diseases remain the leading cause of death worldwide, with antibiotic resistance increasing exponentially due to a lack of new treatments. In addition to this, many pathogens share the common trait of having the ability to modulate, and escape from, the host immune response. The challenge in medical microbiology is to develop and apply new experimental approaches that allow for the identification of both the microbe and its drug susceptibility profile in a time-sensitive manner, as well as to elucidate their molecular mechanisms of survival and immunomodulation. Over the last three decades, proteomics has contributed to a better understanding of the underlying molecular mechanisms responsible for microbial drug resistance and pathogenicity. Proteomics has gained new momentum as a result of recent advances in mass spectrometry. Indeed, mass spectrometry-based biomedical research has been made possible thanks to technological advances in instrumentation capability and the continuous improvement of sample processing and workflows. For example, high-throughput applications such as SWATH or Trapped ion mobility enable the identification of thousands of proteins in a matter of minutes. This type of rapid, in-depth analysis, combined with other advanced, supportive applications such as data processing and artificial intelligence, presents a unique opportunity to translate knowledge-based findings into measurable impacts like new antimicrobial biomarkers and drug targets. In relation to the Research Topic “Proteomic Approaches to Unravel Mechanisms of Resistance and Immune Evasion of Bacterial Pathogens,” this review specifically seeks to highlight the synergies between the powerful fields of modern proteomics and microbiology, as well as bridging translational opportunities from biomedical research to clinical practice.
Infectomics: genomics and proteomics of microbial infections

Sheng-He Huang,Timothy Triche,Ambrose Y. Jong

DOI: https://doi.org/10.1007/s10142-002-0048-4

2002-01-01

Functional & Integrative Genomics

Abstract: The completion of genomic sequences is the greatest triumph of molecular reductionism since the discovery of the DNA double helix in 1953. However, the utility of reductionism is becoming limited and holistic approaches, including theories and techniques, are desperately needed in the postgenomic era. In the field of infectious diseases there is an urgent need for global approaches that can efficiently, precisely and integratively study structural and functional genomics and proteomics of microbial infections (infectomics). The combination of new (e.g. DNA and protein microarrays) and traditional approaches (e.g. cloning, PCR, gene knockout and knockin, and antisense) will help overcome the challenges we are facing today. We assume that the global phenotypic changes (infectomes) in microbes and their host during infections are encoded by the genomes of microbial pathogens and their hosts, expressed in certain environmental conditions devoted to specific microbe-host interactions. Global drug responses (pharmacomes) in microbes and their host can be detected by genomic and proteomic approaches. Genome-wide approaches to genotyping and phenotyping or expression profiling will eventually lead to global dissection of microbial pathogenesis, efficient and rapid diagnosis of infectious diseases, and the development of novel strategies to control infections. The key fundamental issue of infectious diseases is how to globally and integratively understand the interactions between microbial pathogens and their hosts by using infectomics. In this review, we focus on the events that are considered important in infectomics.
Omics for deciphering oral microecology

Yongwang Lin,Xiaoyue Liang,Zhengyi Li,Tao Gong,Biao Ren,Yuqing Li,Xian Peng

DOI: https://doi.org/10.1038/s41368-023-00264-x

IF: 24.897

2024-01-11

International Journal of Oral Science

Abstract:The human oral microbiome harbors one of the most diverse microbial communities in the human body, playing critical roles in oral and systemic health. Recent technological innovations are propelling the characterization and manipulation of oral microbiota. High-throughput sequencing enables comprehensive taxonomic and functional profiling of oral microbiomes. New long-read platforms improve genome assembly from complex samples. Single-cell genomics provides insights into uncultured taxa. Advanced imaging modalities including fluorescence, mass spectrometry, and Raman spectroscopy have enabled the visualization of the spatial organization and interactions of oral microbes with increasing resolution. Fluorescence techniques link phylogenetic identity with localization. Mass spectrometry imaging reveals metabolic niches and activities while Raman spectroscopy generates rapid biomolecular fingerprints for classification. Culturomics facilitates the isolation and cultivation of novel fastidious oral taxa using high-throughput approaches. Ongoing integration of these technologies holds the promise of transforming our understanding of oral microbiome assembly, gene expression, metabolites, microenvironments, virulence mechanisms, and microbe-host interfaces in the context of health and disease. However, significant knowledge gaps persist regarding community origins, developmental trajectories, homeostasis versus dysbiosis triggers, functional biomarkers, and strategies to deliberately reshape the oral microbiome for therapeutic benefit. The convergence of sequencing, imaging, cultureomics, synthetic systems, and biomimetic models will provide unprecedented insights into the oral microbiome and offer opportunities to predict, prevent, diagnose, and treat associated oral diseases.

dentistry, oral surgery & medicine
Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions

Padhmanand Sudhakar,Kathleen Machiels,Bram Verstockt,Tamas Korcsmaros,Séverine Vermeire

DOI: https://doi.org/10.3389/fmicb.2021.618856

IF: 5.2

2021-05-11

Frontiers in Microbiology

Abstract:The microbiome, by virtue of its interactions with the host, is implicated in various host functions including its influence on nutrition and homeostasis. Many chronic diseases such as diabetes, cancer, inflammatory bowel diseases are characterized by a disruption of microbial communities in at least one biological niche/organ system. Various molecular mechanisms between microbial and host components such as proteins, RNAs, metabolites have recently been identified, thus filling many gaps in our understanding of how the microbiome modulates host processes. Concurrently, high-throughput technologies have enabled the profiling of heterogeneous datasets capturing community level changes in the microbiome as well as the host responses. However, due to limitations in parallel sampling and analytical procedures, big gaps still exist in terms of how the microbiome mechanistically influences host functions at a system and community level. In the past decade, computational biology and machine learning methodologies have been developed with the aim of filling the existing gaps. Due to the agnostic nature of the tools, they have been applied in diverse disease contexts to analyze and infer the interactions between the microbiome and host molecular components. Some of these approaches allow the identification and analysis of affected downstream host processes. Most of the tools statistically or mechanistically integrate different types of -omic and meta -omic datasets followed by functional/biological interpretation. In this review, we provide an overview of the landscape of computational approaches for investigating mechanistic interactions between individual microbes/microbiome and the host and the opportunities for basic and clinical research. These could include but are not limited to the development of activity- and mechanism-based biomarkers, uncovering mechanisms for therapeutic interventions and generating integrated signatures to stratify patients.

microbiology
Network analyses in microbiome based on high-throughput multi-omics data.

Zhaoqian Liu,Anjun Ma,Ewy Mathé,Marlena Merling,Qin Ma,Bingqiang Liu

DOI: https://doi.org/10.1093/bib/bbaa005

IF: 9.5

2021-01-01

Briefings in Bioinformatics

Abstract:Together with various hosts and environments, ubiquitous microbes interact closely with each other forming an intertwined system or community. Of interest, shifts of the relationships between microbes and their hosts or environments are associated with critical diseases and ecological changes. While advances in high-throughput Omics technologies offer a great opportunity for understanding the structures and functions of microbiome, it is still challenging to analyse and interpret the omics data. Specifically, the heterogeneity and diversity of microbial communities, compounded with the large size of the datasets, impose a tremendous challenge to mechanistically elucidate the complex communities. Fortunately, network analyses provide an efficient way to tackle this problem, and several network approaches have been proposed to improve this understanding recently. Here, we systemically illustrate these network theories that have been used in biological and biomedical research. Then, we review existing network modelling methods of microbial studies at multiple layers from metagenomics to metabolomics and further to multi-omics. Lastly, we discuss the limitations of present studies and provide a perspective for further directions in support of the understanding of microbial communities.
Integrative Multi-Omics Approaches to Explore Immune Cell Functions: Challenges and Opportunities.

Xu Wang,Dian Fan,Yuqing Yang,Ryan C. Gimple,Shengtao Zhou

DOI: https://doi.org/10.1016/j.isci.2023.106359

IF: 5.8

2023-01-01

iScience

Abstract:As modern biological sciences evolve from investigation of individual molecules and pathways to growing emphasis on global and systems-based processes, increasing efforts have focused on combining the study of genomics with that of the other omics technologies, including epigenomics, transcriptomics, quantitative proteomics, global analyses of post-translational modifications (PTMs) and metabolomics, to characterize specific biological or pathological processes. In addition, emerging genome-wide functional screening technologies further help researchers identify key regulators of immune functions. Derived from these multi-omics technologies, single cell sequencing analysis on multiple layers offers an overview of intra-tissue or intra-organ immune cell heterogeneity. In this review, we summarize advances in multi-omics tools to explore immune cell functions and applications of these multi-omics approaches in the analysis of clinical immune disorders, aiming to provide an outlook on the potential opportunities and challenges that these technologies pose in future investigation in the field of immunology.
Editorial: Genomic and evolutionary analysis of microsporidian parasites.

Qiang Huang,Hamed Mirjalali,Zeyang Zhou

DOI: https://doi.org/10.3389/fmicb.2023.1248661

IF: 5.2

2023-01-01

Frontiers in Microbiology

Abstract:EDITORIAL article Front. Microbiol., 07 July 2023Sec. Evolutionary and Genomic Microbiology Volume 14 - 2023 | https://doi.org/10.3389/fmicb.2023.1248661
Metaomics in Clinical Laboratory: Potential Driving Force for Innovative Disease Diagnosis

Liang Wang,Fen Li,Bin Gu,Pengfei Qu,Qinghua Liu,Junjiao Wang,Jiawei Tang,Shubin Cai,Qi Zhao,Zhong Ming

DOI: https://doi.org/10.3389/fmicb.2022.883734

IF: 5.2

2022-06-18

Frontiers in Microbiology

Abstract:Currently, more and more studies suggested that reductionism was lack of holistic and integrative view of biological processes, leading to limited understanding of complex systems like microbiota and the associated diseases. In fact, microbes are rarely present in individuals but normally live in complex multispecies communities. With the recent development of a variety of metaomics techniques, microbes could be dissected dynamically in both temporal and spatial scales. Therefore, in-depth understanding of human microbiome from different aspects such as genomes, transcriptomes, proteomes, and metabolomes could provide novel insights into their functional roles, which also holds the potential in making them diagnostic biomarkers in many human diseases, though there is still a huge gap to fill for the purpose. In this mini-review, we went through the frontlines of the metaomics techniques and explored their potential applications in clinical diagnoses of human diseases, e.g., infectious diseases, through which we concluded that novel diagnostic methods based on human microbiomes shall be achieved in the near future, while the limitations of these techniques such as standard procedures and computational challenges for rapid and accurate analysis of metaomics data in clinical settings were also examined.

microbiology
Streptococcus Suis in Omics-Era: Where Do We Stand?

Youjun Feng,Zuowei Wu

DOI: https://doi.org/10.4172/2155-9597.s2-001

2011-01-01

Journal of Bacteriology & Parasitology

Abstract:Streptococcus suis (S. suis), a group of heterogeneous species with thirty-five serotypes, is considered a previously-neglected but recently-emerging human pathogen.Lack of full understanding of molecular mechanism by which this group of pathogenic bacteria infects both swine and humans greatly hampered the availability of specific/effective therapeutics against severe S. suis infections.The release of the first genomic sequence of S. suis announced the arrival of its "Omics-Era".This review concentrates on recent highlights of S. suis studies in aspects of Omics.Also, we discussed remaining research gaps and future perspectives.
The -Omics Era- Toward a Systems-Level Understanding of Streptomyces

Zhan Zhou,Jianying Gu,Yi-Ling Du,Yong-Quan Li,Yufeng Wang

DOI: https://doi.org/10.2174/138920211797248556

2011-01-01

Current Genomics

Abstract:Streptomyces is a group of soil bacteria of medicinal, economic, ecological, and industrial importance. It is renowned for its complex biology in gene regulation, antibiotic production, morphological differentiation, and stress response. In this review, we provide an overview of the recent advances in Streptomyces biology inspired by -omics based high throughput technologies. In this post-genomic era, vast amounts of data have been integrated to provide significant new insights into the fundamental mechanisms of system control and regulation dynamics of Streptomyces.
Exploring Novel Immunological Interventions Using Immunoinfectomics

Qiqi Zhu,Lin Wang,Suoqin Tang,Hong Cao,Sheng-He Huang

DOI: https://doi.org/10.2174/2211352511311020004

2013-01-01

Anti-Infective Agents

Abstract:The immune system plays an essential role in the pathogenesis, prevention and treatment of infectious diseases. Immunoinfectomics is an emerging field that addresses the interface between the host immune system and pathogens, and studies immunomes and infectomes (immunoinfectomes). Immune responses induced by microbial infections are complex phenomena that supervene on the levels of genomes, and as a result, infection and immunity ultimately depend on immunoinfectomes. The computational and mathematical approaches have shown practical benefits to convert all these complex data into sophisticated computer models of cellular gene and protein networks. The availability of the above methods has resulted in exciting new progress in the discovery and development of drugs and vaccines against infectious diseases with immunoinfectomic approaches. It has been demonstrated that only one single variable domain antibody fragment, referred to as VHH (variable heavy chain antibody) or nanobody, can interact with antigens. Nanobodies display several characteristics superior to the conventional antibodies, including their non-immunogenicity and high thermal and chemical stability. These characteristics make nanobodies strong candidates as targeting agents for infectious diseases. Recently, tremendous progress has been made in immune epitope mapping and vaccine candidate identification through the use of the immunoinfectomic approaches. These omic approaches provide powerful tools for advances in system biology of microbial infections and the discovery of novel antimicrobial agents. Keywords: Alarmins, epitope, immunomes, infectomes, immunoinfectomes, nanobody, vaccine.
Editorial: Machine learning methods in single-cell immune and drug response prediction

Ren Qi,Quan Zou

DOI: https://doi.org/10.3389/fgene.2023.1233078

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:EDITORIAL article Front. Genet., 19 June 2023Sec. Computational Genomics Volume 14 - 2023 | https://doi.org/10.3389/fgene.2023.1233078
An analysis of human microbe-disease associations.

Wei Ma,Lu Zhang,Pan Zeng,Chuanbo Huang,Jianwei Li,Bin Geng,Jichun Yang,Wei Kong,Xuezhong Zhou,Qinghua Cui

DOI: https://doi.org/10.1093/bib/bbw005

IF: 9.5

2017-01-01

Briefings in Bioinformatics

Abstract:The microbiota living in the human body has critical impacts on our health and disease, but a systems understanding of its relationships with disease remains limited. Here, we use a large-scale text mining-based manually curated microbe disease association data set to construct a microbe-based human disease network and investigate the relationships between microbes and disease genes, symptoms, chemical fragments and drugs. We reveal that microbe-based disease loops are significantly coherent. Microbe-based disease connections have strong overlaps with those constructed by disease genes, symptoms, chemical fragments and drugs. Moreover, we confirm that the microbe-based disease analysis is able to predict novel connections and mechanisms for disease, microbes, genes and drugs. The presented network, methods and findings can be a resource helpful for addressing some issues in medicine, for example, the discovery of bench knowledge and bedside clinical solutions for disease mechanism understanding, diagnosis and therapy.

Editorial: Omics-based Novel Computational Methods Revealing Microbe-Disease Associations

Host and Microbiome Multi-Omics Integration: Applications and Methodologies.

Editorial: Molecular insight of chronic infections.

Editorial: New insights into the role of mycobiome in diseases.

Editorial: the Relationship of Oral and Other Body Sites Microbiome in Human Diseases

Application of Omics and Bioinformatics Tools in Streptococcus Research.

Editorial: Computational and systematic analysis of multi-omics data for drug discovery and development

Editorial: Molecular insights of microbiota and innate lymphoid cell interactions

Editorial: Proteomic Approaches to Unravel Mechanisms of Resistance and Immune Evasion of Bacterial Pathogens

Infectomics: genomics and proteomics of microbial infections

Omics for deciphering oral microecology

Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions

Network analyses in microbiome based on high-throughput multi-omics data.

Integrative Multi-Omics Approaches to Explore Immune Cell Functions: Challenges and Opportunities.

Editorial: Genomic and evolutionary analysis of microsporidian parasites.

Metaomics in Clinical Laboratory: Potential Driving Force for Innovative Disease Diagnosis

Streptococcus Suis in Omics-Era: Where Do We Stand?

The -Omics Era- Toward a Systems-Level Understanding of Streptomyces

Exploring Novel Immunological Interventions Using Immunoinfectomics

Editorial: Machine learning methods in single-cell immune and drug response prediction

An analysis of human microbe-disease associations.